Search Orphan Drug Designations and Approvals
-
| Generic Name: | PTH(1-34)-Cys(succinimido-PEG-vitamin D) amide (human) acetate salt |
|---|---|
| Date Designated: | 05/25/2022 |
| Orphan Designation: | Treatment of hypoparathyroidism |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Extend Biosciences Inc. 90 Bridge St. Suite 100 Newton, Massachusetts 02459 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







